Skip to content
Clinical Trials – home
LuxembourgBack to Luxembourg

Clinical trials in Luxembourg – page 13

153 clinical trials in Luxembourg, Luxembourg across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Luxembourg at a glance
153
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

153 trials in Luxembourg

Open in trial search

Hidradenitis

Not recruiting

Study on the Effectiveness and Safety of Povorcitinib for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.

Acute kidney injury

Not recruiting

Study on Ravulizumab for Protecting Chronic Kidney Disease Patients from Acute Kidney Injury After Heart Surgery

Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Alexion Pharmaceuticals Inc.

Hidradenitis

Not recruiting

Study to Evaluate the Effectiveness of Spesolimab for Patients with Moderate to Severe Hidradenitis Suppurativa

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Spesolimab
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study Comparing Chemotherapy with Nivolumab to Chemotherapy Alone for Patients with Resectable Non-small Cell Lung Cancer

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study on Decitabine, Venetoclax, and Tretinoin for Patients with Acute Myeloid Leukemia Who Cannot Have Induction Chemotherapy

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Medical Center - University Of Freiburg

Plasma cell myeloma

Not recruiting

Study on Elotuzumab, Carfilzomib, Lenalidomide, and Dexamethasone for Patients with Newly Diagnosed Multiple Myeloma

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Carfilzomib
  • Sponsor:Universitaetsklinikum Wuerzburg AöR

Study on Brigatinib, Ceritinib, and Alectinib for Patients with Advanced ALK+ Non-Small Cell Lung Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:Frankfurter Institut Fuer Klinische Krebsforschung IKF GmbH

Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Ibrutinib
  • Sponsor:Klinikum Der Universitat Munchen AöR

Other cities in Luxembourg

The busiest research cities in the country

All 2 cities in Luxembourg

Clinical research in Luxembourg

What the registry says about research in the country

01 Orthopedic Research

Innovative studies focusing on bone reconstruction and healing, particularly examining advanced treatment options for challenging limb conditions and fractures.

  • Lower limb nonunion treatment
  • Lumbar spondylolisthesis therapy
  • Distal radius fracture management

Research emphasizes novel osteogenic implants and their long-term safety profiles in various skeletal conditions.

02 Neurology Studies

Ground-breaking research in Parkinson's disease treatment, investigating new therapeutic approaches for early-stage patients.

  • Motor progression assessment
  • Novel drug interventions
  • Early-stage disease management

Trials focus on evaluating innovative treatments to slow disease progression and improve patient outcomes.

03 Oncology Research

Advanced studies in Small Cell Lung Cancer treatment, exploring combination therapies for extensive disease states.

  • First-line therapy evaluation
  • Immunotherapy combinations
  • Systemic treatment approaches

Research aims to enhance treatment efficacy through innovative drug combinations.

04 Infectious Disease Studies

Comprehensive research on COVID-19 treatments, investigating multiple therapeutic approaches for varying disease severities.

  • Moderate COVID-19 management
  • Severe disease intervention
  • Immunocompromised patient care

Trials evaluate novel therapeutic agents and their efficacy in different patient populations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.